TetraLogic Pharmaceuticals Corporation
TLOG
TLOG was delisted on the 3rd of November, 2016.
31 hedge funds and large institutions have $28.3M invested in TetraLogic Pharmaceuticals Corporation in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
0% more funds holding
Funds holding: 31 → 31 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
7% less capital invested
Capital invested by funds: $30.6M → $28.3M (-$2.25M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHM
Iguana Healthcare Management
New York
|
+$502K |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$250K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$159K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$131K |
| 5 |
Morgan Stanley
New York
|
+$63.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tocqueville Asset Management
New York
|
-$171K |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$115K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$82K |
| 4 |
SIM
Spark Investment Management
New York
|
-$74K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$69.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
26
Glenmede Trust
Philadelphia,
Pennsylvania
| $17K | – | – | – |
|
|
BWA
27
Burt Wealth Advisors
North Bethesda,
Maryland
| $11K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $4K | – | – | – |
|
29
Bank of Montreal
Toronto,
Ontario, Canada
| $4K | +$5.02K | +1,000 | New |
|
30
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $4K | +$5.02K | +1,000 | New |
|
|
BIM
31
BlackRock Investment Management
Wilmington,
Delaware
| $3K | – | – | – |
|
|
TAM
32
Tocqueville Asset Management
New York
| – | -$171K | -35,500 | Closed |
|
|
33
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$82K | -17,140 | Closed |
|
|
SIM
34
Spark Investment Management
New York
| – | -$74K | -15,500 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$8K | -1,816 | Closed |
|
TLOG Hedge Fund Activity: Q1 2015 in Review
31 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q1 2015, worth a combined $28.3M — down 7.4% from $30.6M a quarter earlier.
Fund positioning in TLOG was balanced in Q1 2015: 4 funds opened new positions, 4 closed out, 8 added to existing stakes and 4 trimmed.
The largest buyer was Iguana Healthcare Management, opening a new position worth an estimated $502K. The largest seller was Tocqueville Asset Management, exiting entirely with an estimated $171K sold.
- 31 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $28.3M of TetraLogic Pharmaceuticals Corporation stock for Q1 2015, down 7.4% quarter-over-quarter.
- 4 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q1 2015 and 4 closed out, a net change of 0 holders.
- The largest TetraLogic Pharmaceuticals Corporation buyer in Q1 2015 was Iguana Healthcare Management, an estimated $502K added.
- The largest TetraLogic Pharmaceuticals Corporation seller in Q1 2015 was Tocqueville Asset Management, an estimated $171K sold.
Based on aggregated 13F filings for Q1 2015.